MedPath

Choroid In Coronary Artery Disease

Completed
Conditions
Choroid Diseases
Interventions
Diagnostic Test: OCT
Registration Number
NCT06442176
Lead Sponsor
Bursa Yüksek İhtisas Education and Research Hospital
Brief Summary

Purpose: To investigate any relationship between choroid thickness (CTh) and coronary artery disease (CAD), particularly in its earlier stages before clinically evident.

Design: Retrospective, cross-sectional observational study

Methods:

Setting: The study was performed in two institutions; patients were recruited in Balikesir City Hospital. The ophthalmological examinations and coronary angiograms were performed in Balikesir City Hospital. The analysis of the coronary angiograms including Gensini scoring were conducted in Bursa Education and Research Hospital.

Study Population: The study group comprised 68 patients with documented CAD and 60 healthy control subjects. Patients with high myopia, cataracts, retinal vascular disease, retinal surgery, retinal dystrophy, laser photocoagulation, intravitreal anti-VEGF treatment, glaucoma, uveitis, retinal disorders, any systemic diseases were excluded from the study groups.

Observation Procedure: Refractive examination, corrected visual acuity, intraocular pressure measurements, anterior and posterior segment examinations. Following measurements of macular thickness and retinal nerve fiber layer, choroidal thickness of both eyes was assessed by enhanced depth imaging optical coherence tomography.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
128
Inclusion Criteria
  • Normal coronaries at coronary angiography for healthy control group
  • Without any coronary artery disease equivalent diseases such as peripheral artery disease, cerebrovascular disease and stroke for healthy control group
  • Ability to give informed consent for the study
  • Coronary artery disease with stenosis detected in coronary angiogram for coronary artery disease group
Exclusion Criteria
  • High myopia (> 6D)
  • Cataracts
  • Retinal vascular disease
  • Retinal surgery
  • Retinal dystrophy
  • Laser photocoagulation
  • Intravitreal anti-VEGF treatment
  • Glaucoma
  • Uveitis
  • Retinal disorders (comprising diabetic macular edema, diabetic/hypertensive retinopathy, vein occlusions, retinal dystrophy, epiretinal membrane, vitreomacular traction, age-related macular degeneration)
  • Any systemic diseases
  • Obesity (body-mass index ≥30 kg/m²)

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
Control Healthy groupOCT-
Coronary Artery Disease GroupOCT-
Primary Outcome Measures
NameTimeMethod
Choroidal thickness in patients with coronary artery disease1 day

micron

Choroidal thickness in Healthy Subjects1 day

micron

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Balikesir City Hospital

🇹🇷

Balıkesir, Turkey

© Copyright 2025. All Rights Reserved by MedPath